RNAI REVOLUTION Trademark

Trademark Overview


On Monday, June 17, 2024, a trademark application was filed for RNAI REVOLUTION with the United States Patent and Trademark Office. The USPTO has given the RNAI REVOLUTION trademark a serial number of 98603908. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, April 21, 2026. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The RNAI REVOLUTION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research; scientific research in the fields of pharmaceuticals and medicine, chemical and medical laboratories; Providing scientific information in the field of biopharmaceuticals
rnai revolution

General Information


Serial Number98603908
Word MarkRNAI REVOLUTION
Filing DateMonday, June 17, 2024
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, April 21, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 22, 2025

Trademark Statements


Goods and ServicesScientific research; scientific research in the fields of pharmaceuticals and medicine, chemical and medical laboratories; Providing scientific information in the field of biopharmaceuticals
Pseudo MarkRIBONUCLEIC ACID INTERFERENCE REVOLUTION; RNA INTERFERENCE REVOLUTION
NOT AVAILABLE"RNAI"
Description of MarkThe mark consists of the stylized words "RNAi Revolution" in white, with each letter "i" shadowed by a letter "i" in light blue, and a letter "i" in a pale blue. The color black represents background, outlining, shading, and/or transparent area and is not part of the mark.
Indication of Colors claimedThe color(s) white and blue is/are claimed as a feature of the mark.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 17, 2024
Primary Code042
First Use Anywhere DateFriday, December 31, 2021
First Use In Commerce DateFriday, December 31, 2021

Trademark Owner History


Party NameAlnylam Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
US

Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
US

Trademark Events


Event DateEvent Description
Monday, June 17, 2024NEW APPLICATION ENTERED
Sunday, January 12, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 13, 2025ASSIGNED TO EXAMINER
Monday, January 13, 2025NON-FINAL ACTION WRITTEN
Monday, January 13, 2025NON-FINAL ACTION E-MAILED
Monday, January 13, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 20, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 20, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 20, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 16, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 22, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 22, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 17, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 21, 2025TEAS STATEMENT OF USE RECEIVED
Friday, November 21, 2025USE AMENDMENT FILED
Tuesday, April 21, 2026STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 21, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 21, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED